Alpha-GPC – a Substance with a Very Long Name

1. What Is It Actually?

Alpha-GPC is the abbreviation for a name that is really long: L-Alpha-Glycerylphosphorylcholine. It sounds as though someone deliberately made something difficult up, does it not? If you break the name into pieces, it becomes friendlier. Glycerine is in there, a building block you know from soap. Phosphorus is in there, a substance that also occurs in your bones. And choline is in there, a small building block that cells need. These parts are like Lego bricks that have been joined together. Together they form a single, clearly defined substance. Not a mixture of many ingredients, but one single thing. That matters when researchers work with it. With a mixture you never know exactly which part causes something. With Alpha-GPC the same thing is always inside. And one more point: Alpha-GPC is not a vitamin and not a mineral. It is also not a herb and not a root. It is a substance that researchers can describe precisely in studies. What they want to find out we shall look at in a moment.

2. Where Does It Come From?

You will not find Alpha-GPC if you walk through the woods. It does not hang on a tree and does not grow in a bed. It is produced in laboratories where researchers work. Why is that so? Because a substance that is being studied must be the same every time. If something different were in the glass today than tomorrow, no one could say what an outcome depended on. That is why Alpha-GPC reaches the hand in such a way that the same thing is always in it. The building blocks it consists of you already know from everyday life: glycerine, phosphorus and choline. Glycerine is in soap, phosphorus in your bones, and choline is a small building block for cells. In the body such substances work together, rather like a team.

3. What Are the Researchers Investigating?

There are twenty studies on Alpha-GPC. Five of them were carried out with humans, and two of these five were controlled. Controlled means: there is a comparison group. One group receives the substance, the other receives something else, and then one sees whether the groups develop differently. Such a comparison is the fairest way researchers have. One of the human studies looked at whether Alpha-GPC helps people with a condition in which memory declines sharply. Another examined people with a very serious brain disease in which cells grow uncontrollably. The remaining studies were not carried out with humans. Many questions are first clarified in the laboratory, on individual cells or on animals. That is a usual first step. What exactly emerged from all this is still open. One hypothesis is that the body breaks the substance down into its own building blocks and re-uses them. Whether that makes a difference for some people is a question that continues to be studied.

4. An Experiment to Think About

Imagine you want to know whether your new bicycle is faster than the old one. You ride the new one on a route and are satisfied. Finished? No. Perhaps the wind was behind you, perhaps it went downhill. So you do it better: you ride both bicycles the same route, on the same day, in the same wind. Then you compare. That is exactly what researchers do with a controlled study: two groups, the same conditions, only one thing is different. The next time you hear someone say “That helps, I felt it”, you can ask: What was it compared with? And was it the same for others? These two questions are the beginning of real research.

For adults and professionals: the detailed page on Alpha-GPC (L-Alpha-Glycerylphosphorylcholine).